Sinovac Biotech SVA Income Statement (2010-2025)

NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT
Reported Financials

Sinovac Biotech Quarterly Income Statement

Periods 16 quarters
Latest Dec 2025

Sinovac Biotech income statement data for the quarter ended Dec 2025. This income statement covers 16 quarters of results from Dec 2010 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024 Dec2025
Additional items
Shares Outstanding 53.06M54.61M54.93M55.30M55.68M56.31M56.95M57.03M64.73M94.88M98.90M99.31M99.50M99.61M71.86M71.86M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 53.06M54.61M54.93M55.80M55.68M56.31M56.95M57.10M64.98M109.69M113.66M114.01M114.17M99.61M71.86M71.86M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 54.31M54.77M55.09M55.57M55.81M56.91M57.01M57.28M71.14M98.90M99.29M99.50M99.50M99.64M71.86M71.86M

Sinovac Biotech Income Statement API

Pull Sinovac Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SVA&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY